154 related articles for article (PubMed ID: 37061309)
1. Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South Africa.
Ruperez M; Shanaube K; Mureithi L; Wapamesa C; Burnett MJ; Kosloff B; de Haas P; Hayes R; Fidler S; Gachie T; Schaap A; Floyd S; Klinkenberg E; Ayles H;
Lancet Glob Health; 2023 May; 11(5):e704-e714. PubMed ID: 37061309
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H;
PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis.
Dhana A; Hamada Y; Kengne AP; Kerkhoff AD; Rangaka MX; Kredo T; Baddeley A; Miller C; Singh S; Hanifa Y; Grant AD; Fielding K; Affolabi D; Merle CS; Wachinou AP; Yoon C; Cattamanchi A; Hoffmann CJ; Martinson N; Mbu ET; Sander MS; Balcha TT; Skogmar S; Reeve BWP; Theron G; Ndlangalavu G; Modi S; Cavanaugh J; Swindells S; Chaisson RE; Ahmad Khan F; Howard AA; Wood R; Thit SS; Kyi MM; Hanson J; Drain PK; Shapiro AE; Kufa T; Churchyard G; Nguyen DT; Graviss EA; Bjerrum S; Johansen IS; Gersh JK; Horne DJ; LaCourse SM; Al-Darraji HAA; Kamarulzaman A; Kempker RR; Tukvadze N; Barr DA; Meintjes G; Maartens G
Lancet Infect Dis; 2022 Apr; 22(4):507-518. PubMed ID: 34800394
[TBL] [Abstract][Full Text] [Related]
4. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study.
Reeve BWP; Ndlangalavu G; Mishra H; Palmer Z; Tshivhula H; Rockman L; Naidoo S; Mbu DL; Naidoo CC; Derendinger B; Walzl G; Malherbe ST; van Helden PD; Semitala FC; Yoon C; Gupta RK; Noursadeghi M; Warren RM; Theron G
Lancet Glob Health; 2024 May; 12(5):e793-e803. PubMed ID: 38583458
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey.
Moyo S; Ismail F; Van der Walt M; Ismail N; Mkhondo N; Dlamini S; Mthiyane T; Chikovore J; Oladimeji O; Mametja D; Maribe P; Seocharan I; Ximiya P; Law I; Tadolini M; Zuma K; Manda S; Sismanidis C; Pillay Y; Mvusi L
Lancet Infect Dis; 2022 Aug; 22(8):1172-1180. PubMed ID: 35594897
[TBL] [Abstract][Full Text] [Related]
6. Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study.
Mishra H; Reeve BWP; Palmer Z; Caldwell J; Dolby T; Naidoo CC; Jackson JG; Schumacher SG; Denkinger CM; Diacon AH; van Helden PD; Marx FM; Warren RM; Theron G
Lancet Respir Med; 2020 Apr; 8(4):368-382. PubMed ID: 32066534
[TBL] [Abstract][Full Text] [Related]
7. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189
[TBL] [Abstract][Full Text] [Related]
8. Optimising Xpert-Ultra and culture testing to reliably measure tuberculosis prevalence in the community: findings from surveys in Zambia and South Africa.
Floyd S; Klinkenberg E; de Haas P; Kosloff B; Gachie T; Dodd PJ; Ruperez M; Wapamesa C; Burnett MJ; Kalisvaart N; Vermaak R; Mainga T; Schaap A; Fidler S; Mureithi L; Shanaube K; Hayes R; Ayles H;
BMJ Open; 2022 Jun; 12(6):e058195. PubMed ID: 35710250
[TBL] [Abstract][Full Text] [Related]
9. Screening tests for active pulmonary tuberculosis in children.
Vonasek B; Ness T; Takwoingi Y; Kay AW; van Wyk SS; Ouellette L; Marais BJ; Steingart KR; Mandalakas AM
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013693. PubMed ID: 34180536
[TBL] [Abstract][Full Text] [Related]
10. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
[TBL] [Abstract][Full Text] [Related]
11. Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019.
Matji R; Maama L; Roscigno G; Lerotholi M; Agonafir M; Sekibira R; Law I; Tadolini M; Kak N
PLoS One; 2023; 18(3):e0273245. PubMed ID: 36893175
[TBL] [Abstract][Full Text] [Related]
12. Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa.
Lawn SD; Kerkhoff AD; Burton R; Schutz C; van Wyk G; Vogt M; Pahlana P; Nicol MP; Meintjes G
BMC Med; 2015 Aug; 13():192. PubMed ID: 26275908
[TBL] [Abstract][Full Text] [Related]
13. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.
Yoon C; Semitala FC; Atuhumuza E; Katende J; Mwebe S; Asege L; Armstrong DT; Andama AO; Dowdy DW; Davis JL; Huang L; Kamya M; Cattamanchi A
Lancet Infect Dis; 2017 Dec; 17(12):1285-1292. PubMed ID: 28847636
[TBL] [Abstract][Full Text] [Related]
14. Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.
Di Tanna GL; Khaki AR; Theron G; McCarthy K; Cox H; Mupfumi L; Trajman A; Zijenah LS; Mason P; Bandason T; Durovni B; Bara W; Hoelscher M; Clowes P; Mangu C; Chanda D; Pym A; Mwaba P; Cobelens F; Nicol MP; Dheda K; Churchyard G; Fielding K; Metcalfe JZ
Lancet Glob Health; 2019 Feb; 7(2):e191-e199. PubMed ID: 30683238
[TBL] [Abstract][Full Text] [Related]
15. Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study.
Turner CT; Gupta RK; Tsaliki E; Roe JK; Mondal P; Nyawo GR; Palmer Z; Miller RF; Reeve BW; Theron G; Noursadeghi M
Lancet Respir Med; 2020 Apr; 8(4):407-419. PubMed ID: 32178775
[TBL] [Abstract][Full Text] [Related]
16. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of C-Reactive Protein for Tuberculosis Detection in General-Population Screening and Ambulatory-Care Triage in Uganda.
Cox SR; Erisa KC; Kitonsa PJ; Nalutaaya A; Nantale M; Kayondo F; Mukiibi J; Mukiibi M; Nakasolya O; Dowdy DW; Katamba A; Kendall EA
Ann Am Thorac Soc; 2024 Jun; 21(6):875-883. PubMed ID: 38259069
[No Abstract] [Full Text] [Related]
18. Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa.
Gupta-Wright A; Ha H; Abdulgadar S; Crowder R; Emmanuel J; Mukwatamundu J; Marcelo D; Phillips PPJ; Christopher DJ; Nhung NV; Theron G; Yu C; Nahid P; Cattamanchi A; Worodria W; Denkinger CM;
Lancet Glob Health; 2024 Feb; 12(2):e226-e234. PubMed ID: 38245113
[TBL] [Abstract][Full Text] [Related]
19. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
[TBL] [Abstract][Full Text] [Related]
20. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
